Gertraud Maskarinec to Mammary Glands, Human
This is a "connection" page, showing publications Gertraud Maskarinec has written about Mammary Glands, Human.
Connection Strength
3.458
-
Maskarinec G, Ju D, Fong J, Horio D, Chan O, Loo LWM, Hernandez BY. Mammographic density and breast tissue expression of inflammatory markers, growth factors, and vimentin. BMC Cancer. 2018 Nov 29; 18(1):1191.
Score: 0.657
-
Maskarinec G, Ju D, Horio D, Loo LW, Hernandez BY. Involution of breast tissue and mammographic density. Breast Cancer Res. 2016 12 15; 18(1):128.
Score: 0.574
-
Maskarinec G, Nakamura KL, Woolcott CG, Conroy SM, Byrne C, Nagata C, Ursin G, Vachon CM. Mammographic density and breast cancer risk by family history in women of white and Asian ancestry. Cancer Causes Control. 2015 Apr; 26(4):621-6.
Score: 0.508
-
Morimoto Y, Killeen J, Hernandez BY, Mark Cline J, Maskarinec G. Parity and expression of epithelial histopathologic markers in breast tissue. Eur J Cancer Prev. 2013 Sep; 22(5):404-8.
Score: 0.457
-
Maskarinec G, Pagano IS, Little MA, Conroy SM, Park SY, Kolonel LN. Mammographic density as a predictor of breast cancer survival: the Multiethnic Cohort. Breast Cancer Res. 2013 Jan 22; 15(1):R7.
Score: 0.438
-
Maskarinec G. The human mammary gland as a target for isoflavones: how does the relation vary in individuals with different ethnicity? Planta Med. 2013 May; 79(7):554-61.
Score: 0.433
-
McCormack VA, Burton A, dos-Santos-Silva I, Hipwell JH, Dickens C, Salem D, Kamal R, Hartman M, Lee CP, Chia KS, Ozmen V, Aribal ME, Flugelman AA, Lajous M, Lopez-Riduara R, Rice M, Romieu I, Ursin G, Qureshi S, Ma H, Lee E, van Gils CH, Wanders JO, Vinayak S, Ndumia R, Allen S, Vinnicombe S, Moss S, Won Lee J, Kim J, Pereira A, Garmendia ML, Sirous R, Sirous M, Peplonska B, Bukowska A, Tamimi RM, Bertrand K, Nagata C, Kwong A, Vachon C, Scott C, Perez-Gomez B, Pollan M, Maskarinec G, Giles G, Hopper J, Stone J, Rajaram N, Teo SH, Mariapun S, Yaffe MJ, Sch?z J, Chiarelli AM, Linton L, Boyd NF. International Consortium on Mammographic Density: Methodology and population diversity captured across 22 countries. Cancer Epidemiol. 2016 Feb; 40:141-51.
Score: 0.134
-
Rudolph A, Fasching PA, Behrens S, Eilber U, Bolla MK, Wang Q, Thompson D, Czene K, Brand JS, Li J, Scott C, Pankratz VS, Brandt K, Hallberg E, Olson JE, Lee A, Beckmann MW, Ekici AB, Haeberle L, Maskarinec G, Le Marchand L, Schumacher F, Milne RL, Knight JA, Apicella C, Southey MC, Kapuscinski MK, Hopper JL, Andrulis IL, Giles GG, Haiman CA, Khaw KT, Luben R, Hall P, Pharoah PD, Couch FJ, Easton DF, Dos-Santos-Silva I, Vachon C, Chang-Claude J. A comprehensive evaluation of interaction between genetic variants and use of menopausal hormone therapy on mammographic density. Breast Cancer Res. 2015 Aug 16; 17:110.
Score: 0.131
-
Stone J, Thompson DJ, Dos Santos Silva I, Scott C, Tamimi RM, Lindstrom S, Kraft P, Hazra A, Li J, Eriksson L, Czene K, Hall P, Jensen M, Cunningham J, Olson JE, Purrington K, Couch FJ, Brown J, Leyland J, Warren RM, Luben RN, Khaw KT, Smith P, Wareham NJ, Jud SM, Heusinger K, Beckmann MW, Douglas JA, Shah KP, Chan HP, Helvie MA, Le Marchand L, Kolonel LN, Woolcott C, Maskarinec G, Haiman C, Giles GG, Baglietto L, Krishnan K, Southey MC, Apicella C, Andrulis IL, Knight JA, Ursin G, Alnaes GI, Kristensen VN, Borresen-Dale AL, Gram IT, Bolla MK, Wang Q, Michailidou K, Dennis J, Simard J, Pharoah P, Dunning AM, Easton DF, Fasching PA, Pankratz VS, Hopper JL, Vachon CM. Novel Associations between Common Breast Cancer Susceptibility Variants and Risk-Predicting Mammographic Density Measures. Cancer Res. 2015 Jun 15; 75(12):2457-67.
Score: 0.128